AR023818A1 - Sistema de activacion de cimogeno - Google Patents
Sistema de activacion de cimogenoInfo
- Publication number
- AR023818A1 AR023818A1 ARP000102081A ARP000102081A AR023818A1 AR 023818 A1 AR023818 A1 AR 023818A1 AR P000102081 A ARP000102081 A AR P000102081A AR P000102081 A ARP000102081 A AR P000102081A AR 023818 A1 AR023818 A1 AR 023818A1
- Authority
- AR
- Argentina
- Prior art keywords
- cytogen
- precursor
- activation
- catalytic activity
- protease gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30316299A | 1999-04-30 | 1999-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023818A1 true AR023818A1 (es) | 2002-09-04 |
Family
ID=23170790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000102081A AR023818A1 (es) | 1999-04-30 | 2000-04-28 | Sistema de activacion de cimogeno |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1173590A4 (fr) |
JP (1) | JP2003531567A (fr) |
AR (1) | AR023818A1 (fr) |
AU (1) | AU4239600A (fr) |
CA (1) | CA2372907A1 (fr) |
WO (1) | WO2000066709A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006271285A (ja) * | 2005-03-30 | 2006-10-12 | National Institute Of Information & Communication Technology | 改良型haタグ及び改良型haタグを用いたスクリーニング方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200340A (en) * | 1987-05-22 | 1993-04-06 | Zymogenetics, Inc. | Thrombin-activated tissue plasminogen activators |
US5504001A (en) * | 1987-11-25 | 1996-04-02 | Zymogenetics, Inc. | Hybrid plasminogen activator |
US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
US5196322A (en) * | 1987-12-28 | 1993-03-23 | Eli Lilly And Company | Vectors and compounds for expression of zymogen forms of human protein C |
US5342762A (en) * | 1991-01-03 | 1994-08-30 | Wisconsin Alumni Research Foundation | Fibronectin purification vector |
CA2153254C (fr) * | 1993-01-15 | 2002-05-21 | Edward R. Lavallie | Clonage d'enterokinase et methode d'utilisation |
DK82893D0 (da) * | 1993-07-08 | 1993-07-08 | Novo Nordisk As | Peptid |
ATE277172T1 (de) * | 1996-06-11 | 2004-10-15 | Roche Diagnostics Gmbh | Rekombinante blutgerinnungsproteasen |
ES2273414T3 (es) * | 1997-04-25 | 2007-05-01 | Sembiosys Genetics Inc. | Procedimiento para el corte de proteinas de fusion. |
-
2000
- 2000-04-13 CA CA002372907A patent/CA2372907A1/fr not_active Abandoned
- 2000-04-13 WO PCT/US2000/009973 patent/WO2000066709A2/fr not_active Application Discontinuation
- 2000-04-13 AU AU42396/00A patent/AU4239600A/en not_active Abandoned
- 2000-04-13 EP EP00922167A patent/EP1173590A4/fr not_active Withdrawn
- 2000-04-13 JP JP2000615734A patent/JP2003531567A/ja active Pending
- 2000-04-28 AR ARP000102081A patent/AR023818A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1173590A4 (fr) | 2003-01-15 |
WO2000066709A2 (fr) | 2000-11-09 |
JP2003531567A (ja) | 2003-10-28 |
CA2372907A1 (fr) | 2000-11-09 |
AU4239600A (en) | 2000-11-17 |
WO2000066709A3 (fr) | 2001-02-15 |
EP1173590A2 (fr) | 2002-01-23 |
WO2000066709A9 (fr) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cameron et al. | Polyarginines are potent furin inhibitors | |
Ramirez et al. | Extensive peptide and natural protein substrate screens reveal that mouse caspase-11 has much narrower substrate specificity than caspase-1 | |
Lu et al. | Designed semisynthetic protein inhibitors of Ub/Ubl E1 activating enzymes | |
Doucet et al. | Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome | |
Debela et al. | Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences | |
Remacle et al. | Substrate cleavage analysis of furin and related proprotein convertases: a comparative study | |
Turk et al. | Determination of protease cleavage site motifs using mixture-based oriented peptide libraries | |
York et al. | Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation | |
St. Hilaire et al. | Fluorescence-quenched solid phase combinatorial libraries in the characterization of cysteine protease substrate specificity | |
Mahrus et al. | Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B | |
MA29958B1 (fr) | Procede pour olefines internes | |
DK0771209T3 (da) | Hidtil ukendte peptider | |
NO981169D0 (no) | Pneumokokkiske gener, deler derav, ekspresjonsprodukter fra disse samt anvendelse av slike gener, deler og produkter | |
Cao et al. | Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase | |
Wang et al. | Biochemical tools for tracking proteolysis | |
WO2001016289A3 (fr) | Systeme d'activation de zymogenes | |
Fugere et al. | Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences | |
BR9815469A (pt) | Inibidores de protease | |
Zamolodchikova et al. | Activation of recombinant proenteropeptidase by duodenase | |
Hattori et al. | BACE1 interacts with nicastrin | |
Mzhavia et al. | Characterization of endothelin-converting enzyme-2: Implication for a role in the nonclassical processing of regulatory peptides | |
BRPI0513267A (pt) | variantes melhoradas de aprotinina | |
ID23393A (id) | Produk makanan beku | |
Nguyen et al. | Protease specificity profiling in a pipet tip using “Charge-Synchronized” proteome-derived peptide libraries | |
AR023818A1 (es) | Sistema de activacion de cimogeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |